Tiburio Therapeutics Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Tiburio Therapeutics Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2019.
Tiburio Therapeutics at a glance
What does Tiburio Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $5 million sold (2019).
Frequently asked questions about Tiburio Therapeutics
Where is Tiburio Therapeutics headquartered?
Tiburio Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Tiburio Therapeutics do?
Tiburio Therapeutics Inc. is a pharmaceutical company.
When was Tiburio Therapeutics founded?
The earliest incorporation on record for Tiburio Therapeutics Inc. is in 2018, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences